Keh et al. report that Guillain-Barre syndrome is associated with first-dose ChAdOx1 nCoV-19 vaccine at 5.8 cases per million vaccinations. No specific phenotype differentiates vaccine-associated GBS. https://t.co/KHEGFadfmp pic.twitter.com/4YlC436D8o
— Brain (@Brain1878) February 20, 2022